US Drug Recall Register
Class III · Low risk Terminated Initiated Mar 11, 2019 (7 years ago)

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotent Drug.

What was recalled

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93

Recalling firm
Teva Pharmaceuticals USA
NDC code
0093-3008-93
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1006-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lansoprazole recalls

See all